Rolf Nüsing Selected Research

Rolf Nüsing Research Topics

Disease

5	Pain (Aches) 01/2020 - 08/2009
3	Inflammation (Inflammations) 10/2020 - 02/2014
2	Neoplasms (Cancer) 01/2022 - 10/2020
1	Angioedema 04/2022
1	Ureteral Obstruction 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hydronephrosis 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hypersensitivity (Allergy) 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Eosinophilia 01/2020
1	Wounds and Injuries (Trauma) 02/2017
1	Neuralgia (Stump Neuralgia) 03/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2014
1	Hyperalgesia 02/2014
1	Hypertension (High Blood Pressure) 12/2009
1	Atherosclerosis 11/2007
1	Patent Ductus Arteriosus 02/2003
1	Congenital Heart Defects (Congenital Heart Defect) 02/2003
1	Pulmonary Edema 09/2002
1	Acute Lung Injury 09/2002
1	Edema (Dropsy) 09/2002
1	Nephrocalcinosis 12/2001
1	Hypercalciuria 12/2001

Drug/Important Bio-Agent (IBA)

6	Dinoprostone (PGE2)FDA Link 01/2022 - 02/2014
5	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2022 - 08/2009
5	ProstaglandinsIBA 01/2022 - 09/2002
3	ThromboxanesIBA 01/2022 - 02/2003
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2017
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2020 - 09/2002
3	EicosanoidsIBA 01/2020 - 11/2007
2	Thromboxane Receptors (Thromboxane Receptor)IBA 01/2022 - 08/2009
2	LipidsIBA 01/2022 - 01/2020
2	EnzymesIBA 01/2020 - 01/2012
2	Cyclooxygenase 1IBA 02/2017 - 08/2009
2	Epoprostenol ReceptorsIBA 03/2014 - 08/2009
2	Prostaglandins EIBA 02/2003 - 09/2002
2	CalciumIBA 09/2002 - 12/2001
1	BradykininIBA 04/2022
1	Prostaglandin-E SynthasesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Thromboxane B2IBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Glutamate DehydrogenaseIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017
1	Diclofenac (SR 38)FDA LinkGeneric 02/2017
1	Cyclooxygenase InhibitorsIBA 03/2014
1	Meloxicam (Mobic)FDA LinkGeneric 03/2014
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2014
1	InterleukinsIBA 03/2014
1	ZymosanIBA 02/2014
1	(2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)IBA 02/2014
1	AmidesIBA 01/2012
1	CannabinoidsIBA 01/2012
1	Dipyrone (Metamizole)IBA 01/2012
1	phosducinIBA 12/2009
1	GTP-Binding Proteins (G-Protein)IBA 12/2009
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 08/2009
1	Formaldehyde (Formol)FDA Link 08/2009
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2007
1	Prostaglandins FIBA 02/2003
1	Prostaglandins DIBA 02/2003
1	Quinine (Quinson)FDA Link 09/2002
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2002
1	paxillineIBA 09/2002
1	PotassiumIBA 09/2002
1	Platelet Activating FactorIBA 09/2002
1	beta dendrotoxinIBA 09/2002
1	Potassium Channels (Potassium Channel)IBA 09/2002
1	MagnesiumIBA 12/2001

Therapy/Procedure

1	Nephrectomy 01/2022
1	Therapeutics 01/2020
1	Intravenous Infusions 02/2003
1	Intravenous Administration 02/2003